We are live on ! Find out more
CYTO

Altamira Therapeutics Ltd
CYTO

Delisted

CYTO was delisted on the 19th of December, 2024.

Back to rankings

12 hedge funds and large institutions have $68.3M invested in Altamira Therapeutics Ltd in 2015 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

81% more capital invested

Capital invested by funds: $37.9M → $68.3M (+$30.5M)

71% more funds holding

Funds holding: 7 → 12 (+5)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
12
Holders Change
+5
Holders Change %
+71.43%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
1
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WA
Wasatch Advisors
Utah
+$14.1M
2
TCM
Tekla Capital Management
Massachusetts
+$10.8M
3
CA
Cortland Advisers
Delaware
+$8.29M
4
OM
Opaleye Management
Massachusetts
+$1.66M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$829K

Top Sellers

Rank Fund Capital Flow
1
CPCM
Clifton Park Capital Management
Delaware
-$415K
2
SFM
Sphera Funds Management
Israel
-$415K
3
SIM
Spark Investment Management
New York
-$85K
4
TRCT
Tower Research Capital (TRC)
New York
-$14K

CYTO Hedge Fund Activity: Q2 2015 in Review

12 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Altamira Therapeutics Ltd (CYTO) for Q2 2015, worth a combined $68.3M — up 81% from $37.9M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new CYTO positions and 0 closed out — a net gain of 5 holders — while 1 added to existing stakes and 2 trimmed.

The largest buyer was Wasatch Advisors, opening a new position worth an estimated $14.1M. The largest seller was Clifton Park Capital Management, cutting an estimated $415K.

  • 12 institutional investors held Altamira Therapeutics Ltd (CYTO) as of Q2 2015, up from 7 in Q1 2015.
  • Funds reported $68.3M of Altamira Therapeutics Ltd stock for Q2 2015, up 81% quarter-over-quarter.
  • 5 funds opened new Altamira Therapeutics Ltd positions in Q2 2015 and 0 closed out, a net change of +5 holders.
  • The largest Altamira Therapeutics Ltd buyer in Q2 2015 was Wasatch Advisors, an estimated $14.1M added.
  • The largest Altamira Therapeutics Ltd seller in Q2 2015 was Clifton Park Capital Management, an estimated $415K sold.

Based on aggregated 13F filings for Q2 2015.